Skip to main content

teriparatide

Generic: TERIPARATIDE ACETATE·Brand: BONSITY, FORTEO, Forteo, PARATHAR, TERIPARATIDE, Yorvipath

teriparatide: 4 clinical trials tracked.

teriparatide evidence translation

What we can confirm

4 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about teriparatide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 1 study sponsors
Clinical Trials (4)

Efficacy of Sequential Denosumab After Teriparatide for 6 Months Compared With Denosumab Monotherapy in Reducing Risk of Osteoporotic Fractures in Patients With New Fractures: a Multicenter Randomized Controlled Trial (STAND Study)

NCT05866029·N/A
Recruiting

Primary endpoint: The main study：The incidence of new vertebral fractures

InterventionalRandomizedsingle2,478 targetStarted 2023-05Completion 2026-0950 sites · ChinaPeking Union Medical College Hospital

A Phase 1b, Open-label, Partially Randomised Study to Assess Safety and Compare Pharmacokinetics of New Oral hPTH(1-34) Tablet Formulations vs. Oral EBP05 Tablets and Subcutaneous Forteo® Injection in Healthy Male Subjects

NCT05965167·Phase 1·ENTX
Completed

Primary endpoint: Assessment of the pharmacokinetic profile of plasma hPTH(1-34) after single or twice daily oral administration for treatment regimen as listed under Arms and Interventions at 5, 10, 15, 20, 40, 50, 60, 75, 90, 105, 120, 180, 240, 360 min. post dose

InterventionalRandomizedopen45 enrolledStarted 2023-05Completion 2026-021 site · IsraelEntera Bio Ltd.

Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action. A Two-year Open-label Single-arm Study of Teriparatide in Secondary Care

NCT01293292·Phase 4
Completed

Primary endpoint: Volumetric bone mineral density (BMD) of the lumbar spine (mg hydroxyapatite/cm3)

Interventionalopen19 enrolledStarted 2011-01Completion 2015-081 site · United KingdomSheffield Teaching Hospitals NHS Foundation Trust

Study on the Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Postmenopausal Women With Osteoporosis

NCT01155245
Active, not recruiting

Primary endpoint: Change in cortical thickness with teriparatide therapy from baseline to 24 months

Observational60 targetStarted 2008-06Completion 2028-011 site · CanadaUniversity Health Network, Toronto